Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.47 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.47 |
| ▸ | AMY2A | P04746 | 4/20 | 0.46 |
| ▸ | CDK1 | P06493 | 1/20 | 0.44 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.41 |
| ▸ | MGAM | O43451 | 2/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cellobiose SCHEMBL12812952 | 1.00 | MEN1 (0.72) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Maltose SCHEMBL322308 | 1.00 | MEN1 (0.72) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL8946716 | 0.93 | MEN1 (0.85) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL8437954 | 0.93 | MEN1 (0.85) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Sucrose SCHEMBL20544169 | 0.91 | MEN1 (0.61) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Cellobiose SCHEMBL6822376 | 0.91 | MEN1 (0.61) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Cellobiose SCHEMBL10926859 | 0.91 | MEN1 (0.61) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Cellobiose SCHEMBL28181308 | 0.90 | MEN1 (0.60) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL29368294 | 0.88 | MEN1 (0.92) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Trehalose SCHEMBL7647243 | 0.88 | MEN1 (0.76) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013091006-A1 | PROCESS FOR DRY POWDER BLENDING | MONASH UNIVERSITY (AU) | 2013-06-27 | — | — | WO | claimed |
| JP-6179617-A | — | — | None | — | — | JP | disclosed |
| WO-2024004883-A1 | ADHESIVE AGENT FOR RESIN, AND LAYERED BODY | 日本パーカライジング株式会社 | 2024-01-04 | — | — | WO | disclosed |
| EP-4262424-A1 | RAPESEED PROTEIN COMPOSITION | DSM IP Assets B.V. (NL) | 2023-10-25 | — | — | EP | disclosed |
| CN-116082707-A | Anti-interference material, anti-interference film, and preparation method and application thereof | 深圳大学 | 2023-05-09 | — | — | CN | disclosed |
| US-20220411950-A1 | ALKALINE ZINC-IRON PLATING BATH | YUKEN INDUSTRY CO., LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| WO-2022129520-A1 | RAPESEED PROTEIN COMPOSITION | DSM IP ASSETS B.V. (NL) | 2022-06-23 | — | — | WO | disclosed |
| US-20220000949-A1 | ANTITUMOR EFFECT POTENTIATOR | NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3858368-A1 | ANTITUMOR EFFECT POTENTIATOR | National Cerebral and Cardiovascular Center (JP) | 2021-08-04 | — | — | EP | disclosed |
| CN-109328058-A | Oral mucosa adhesive material and method for producing same | 株式会社利他药业 | 2019-02-12 | — | — | CN | disclosed |
| EP-0920529-A1 | METHOD OF AND GROWTH MEDIUM FOR DETECTING MICRO-ORGANISMS IN A SAMPLE | The University of Lincolnshire & Humberside (GB) | 1999-06-09 | — | — | EP | disclosed |
| WO-1998007882-A1 | METHOD OF AND GROWTH MEDIUM FOR DETECTING MICRO-ORGANISMS IN A SAMPLE | THE UNIVERSITY OF LINCOLNSHIRE & HUMBERSIDE (GB) | 1998-02-26 | — | — | WO | disclosed |
| US-5698224-A | Tacrine therapy | ALZA CORPORATION (US) | 1997-12-16 | — | — | US | disclosed |
| EP-0768880-A1 | TACRINE PHARMACEUTICAL COMPOSITIONS | ALZA CORPORATION (US) | 1997-04-23 | — | — | EP | disclosed |
| CN-1146158-A | Colon-specific drug release system | YAMANOUCHI PHARMA CO LTD (JP) | 1997-03-26 | — | — | CN | disclosed |
| WO-1996000065-A1 | TACRINE PHARMACEUTICAL COMPOSITIONS | ALZA CORPORATION (US) | 1996-01-04 | — | — | WO | disclosed |
| CN-1107277-A | Novel compound having platelet aggregation inhibiting effect | MEIJI SEIKA CO (JP) | 1995-08-23 | — | — | CN | disclosed |
| JP-H06179617-A | OXYGEN-RICH SUBSTANCE | GOLD KOSAN KK | 1994-06-28 | — | — | JP | disclosed |
| US-5032514-A | Converting glucose to 2-keto-lgulconic acid through 2,5-diketo-d-gluconic acid producing bacterial cell; blcoking secondary metabolic diversion | GENENTECH, INC. (US) | 1991-07-16 | — | — | US | disclosed |
| US-4443544-A | ZYMOMONAS, CARBOHYDRATES, CULTURES, REPLACEMENTS | UNISEARCH LIMITED (AU) | 1984-04-17 | — | — | US | disclosed |